Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
Clinical trial NCT02015494 · UNKNOWN
Trial details
- NCT number
- NCT02015494
- Sponsor
- VaxInnate Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-12-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.